C8A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
Gene SymbolC8A
[^3]
Full NameComplement Component 8 Alpha Chain
[^4]
Chromosomal Location1p31.3
[^5]
NCBI Gene ID[731](https://www.ncbi.nlm.nih.gov/gene/731)
[^6]
OMIM[120550](https://omim.org/entry/120550)
[^7]
Ensembl IDENSG00000157216
UniProt ID[P07360](https://www.uniprot.org/uniprot/P07360)
Associated DiseasesComplement Deficiency, Neiserria Infections
The C8A gene encodes the alpha chain of complement component 8 (C8α), a terminal complement protein essential for membrane attack complex (MAC) formation. C8 is composed of three chains (alpha, beta, and gamma) that form a heterotrimeric complex. The gene is located on chromosome 1p31.3 and encodes a protein of 579 amino acids [1].
C8 is a critical component of the complement terminal pathway. The alpha chain contains a hydrophobic region that inserts into the target cell membrane, while the gamma chain is a lipocalin-like protein. Together with C5b, C6, C7, and C9, C8 participates in forming the cytolytic MAC [2].
The C8 alpha chain functions as:
- Membrane Stabilization: Stabilizes the C5b-7 complex on the target cell membrane
- Scaffold for C9: Provides a platform for C9 polymerization and pore formation
- Pore Formation: Contributes to efficient membrane pore formation by the MAC
- Lipid Binding: The alpha chain contains a lipophilic region that inserts into lipid bilayers
The complete C8 complex (αβγ) binds to C5b-7 to form C5b-8, which then allows C9 polymerization to form the mature MAC (C5b-9).
- C8 Deficiency: Individuals with C8 deficiency have increased susceptibility to Neisseria infections, particularly Neisseria meningitidis
- Recurrent Infections: Lack of functional MAC leads to impaired bacterial killing
- MAC-mediated Injury: Sublytic MAC formation can contribute to neuronal injury in various neurodegenerative conditions
- Glial Activation: MAC deposition may activate glial cells and contribute to neuroinflammation
- Liver: Primary site of synthesis (hepatocytes)
- Brain: Low baseline expression in astrocytes and microglia
- Various tissues: Widely expressed at low levels
- C8 expression is upregulated during acute phase response
- Inflammatory cytokines can modulate C8 synthesis
- C8A polymorphisms may affect complement activity levels
- Rare variants cause hereditary C8 deficiency
- Diagnostic Markers: C8 levels can be measured for complement deficiency workup
- Therapeutic Potential: Modulating C8 activity may have applications in treating complement-mediated diseases
The study of C8A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.